Evan Y. Yu

2001–2026 年に発表

別表記
Evan Y Yu
152
論文数
25,001
被引用数
61
h 指数
137
i10 指数

被引用数

Evan Y. Yu の年別被引用数1984 年: 被引用 1 件1994 年: 被引用 1 件2001 年: 被引用 3 件2002 年: 被引用 13 件2003 年: 被引用 21 件2004 年: 被引用 55 件2005 年: 被引用 47 件2006 年: 被引用 41 件2007 年: 被引用 31 件2008 年: 被引用 29 件2009 年: 被引用 30 件2010 年: 被引用 52 件2011 年: 被引用 89 件2012 年: 被引用 69 件2013 年: 被引用 106 件2014 年: 被引用 135 件2015 年: 被引用 181 件2016 年: 被引用 236 件2017 年: 被引用 319 件2018 年: 被引用 390 件2019 年: 被引用 921 件2020 年: 被引用 1,253 件2021 年: 被引用 1,260 件2022 年: 被引用 1,081 件2023 年: 被引用 799 件2024 年: 被引用 1,326 件2025 年: 被引用 596 件2026 年: 被引用 21 件1985〜1993 年は被引用が無いため表示していません1995〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,875 件、この内訳の 27.7%中国: 引用元論文 1,327 件、この内訳の 9.5%イギリス: 引用元論文 910 件、この内訳の 6.5%イタリア: 引用元論文 731 件、この内訳の 5.2%カナダ: 引用元論文 677 件、この内訳の 4.9%ドイツ: 引用元論文 613 件、この内訳の 4.4%フランス: 引用元論文 565 件、この内訳の 4%スペイン: 引用元論文 486 件、この内訳の 3.5%日本: 引用元論文 417 件、この内訳の 3%オランダ: 引用元論文 383 件、この内訳の 2.7%オーストラリア: 引用元論文 370 件、この内訳の 2.7%スイス: 引用元論文 331 件、この内訳の 2.4%
0%27.7%その他 23.5%

分野

  • Medicine65.2%
  • Biochemistry, Genetics and Molecular Biology28.9%
  • Immunology and Microbiology2.9%
  • Neuroscience0.7%
  • Agricultural and Biological Sciences0.4%
  • Engineering0.4%
  • その他1.5%

トピック

  • Prostate Cancer Treatment and Research11.4%
  • Cancer Immunotherapy and Biomarkers5%
  • Prostate Cancer Diagnosis and Treatment4.7%
  • Bladder and Urothelial Cancer Treatments4.5%
  • Extracellular vesicles in disease2.9%
  • Cancer Genomics and Diagnostics2.4%
  • その他69.1%

共著者

全論文

検索で開く
  1. Integrative Clinical Genomics of Advanced Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 被引用: 3,701

  2. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sanjeev Mariathasan, AnnChristine Thåström, Oyewale O. Abidoye, Gregg Fine, Dean F. Bajorin - The Lancet 2016 被引用: 2,211

  3. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brieuc Sautois, Jean‐Pascal Machiels, Denis Schallier, Leandro Brust, Liane Rapatoni, Sérgio Jobim Azevedo, GISELE LOPES MARINHO, João Paulo Holanda Soares, Carlos Dzik, Jamile Almeida Silva, André P. Fay, Joel Gingerich, Yves Fradet, Cristiano Ferrario, Kylea Potvin, Marie Vanhuyse, Mahmoud Abdelsalam, Susanna Cheng, Christian Caglevic, Felipe Reyes, José Luis Leal, Francisco Francisco, Carolina Ibáñez, Florence Joly, Brigitte Laguerre, Sylvain Ladoire, Aude Fléchon, Delphine Topart, Olivier Huillard, Stéphane Oudard, Marine Gross‐Goupil, Stéphane Culine, Yohann Loriot, Gwénaëlle Gravis, Peter Reichardt, Margitta Retz, Jan Herden, David G. Pfister, Carsten Ohlman, Michael Stöeckle, Manfred P. Wirth, Anja Lorch, Guenter Niegisch, Peter J. Goebell, Martin Boegemann, Axel S. Merseburger, Georgios Gakis, Jens Bedke, Andreas Neisius, Christian A. Thomas, Thomas Hoefner, András Telekes, Judit Kósa, János Révész, Gyorgy Bodoky, Tibor Csőszi, András Csejtei, Lajos Géczi, Ágnes Ruzsa, Zsuzsanna Kolonics, József Erfán, Ray McDermott, Richard Bambury, Avishay Sella, Stephen Jay Frank, Daniel Kejzman, Olesya Goldman, Eli Rosenbaum, Avivit Peer, Raanan Berger ほか 158 名 - The Lancet Oncology 2021 被引用: 648

  4. Lentivirus-delivered stable gene silencing by RNAi in primary cells

    著者: , , , , , , , , , , , - RNA 2003 被引用: 1,646

  5. Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy

    著者: , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 626

  6. Quantitative and stoichiometric analysis of the microRNA content of exosomes

    著者: , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 被引用: 1,095

  7. Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas W. Griffin, Howard I. Scher, Dana E. Rathkopf - New England Journal of Medicine 2012 被引用: 2,795

  8. Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 被引用: 468

  9. The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William L. Dahut, Peter S. Nelson - Clinical Cancer Research 2019 被引用: 394

  10. Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2021 被引用: 267

  11. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2016 被引用: 763

  12. Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Evan Y. Yu - Journal of Clinical Oncology 2023 被引用: 132

  13. Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Schatteman, Nicolaas Lumen, Luc Dirix, Jean-Charles Goeminne, Thierry Gil, Emmanuel Seront, Christof Vulsteke, Celio Kussumoto, Fabio A. Franke, Fabricio Augusto Martinelli de Oliveira, Andrea Juliana Pereira de Santana Gomes, Hélio Pinczowski, Daniel D'Almeida Preto, Luis Eduardo Zucca, Giuliano Santos Borges, Andre M. Murad, Fred Saad, Kim N. Chi, Yves Fradet, Neil E. Fleshner, Urban Emmenegger, Klaus Brasso, Karim Fizazi, Stephane Culine, Antoine Thiery-Vuillemin, Florence Joly, Aude Fléchon, Werner Hilgers, Jean-Christophe Eymard, Delphine Borchiellini, Philippe Barthélémy, Raanan Berger, Raya Leibowitz-Amit, Wilmosh Mermershtain, Keren Rouvinov, Avivit Peer, Svetlana Kovel, Avishay Sella, Martijn P. Lolkema, Alfonsus J.M. van den Eertwegh, Johannes Voortman, Maureen J. Aarts, Jourik A. Gietema, Choung-Soo Kim, Young-Deuk Choi, Byung-Ha Chung, Rustem A. Gafanov, Evgeniy Kopyltsov, Evgeny A. Usynin, Joan Carles, Begoña Mellado, José Pablo Maroto, Jesús García-Donás, Juan Francisco Rodríguez Moreno, Ignacio Durán, Begoña Pérez-Valderrama, Elena Castro, David Olmos, María José Méndez-Vidal, David Lorente Estellés, Regina Gironés Sarrió, José Muñoz-Langa, Urbano Anido Herranz, Javier Puente Vázquez, Enrique Castellanos, Martin Hellström, Anders Widmark, Ingela Franck Lissbrant, Åsa Jellvert, Cecilia Külich ほか 34 名 - The Lancet Oncology 2022 被引用: 186

  14. Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 100

  15. Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference

    著者: , , , , , , , , , , , - JAMA Oncology 2020 被引用: 158

  16. Integrative Clinical Genomics of Advanced Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Andrea Sboner, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 被引用: 591

  17. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacqueline Powers, Raoul S. Concepcion, Daniel W. Lin, Richard C. Wender, James Ryan Mark, Anthony J. Costello, Arthur L. Burnett, Oliver Sartor, William B. Isaacs, Jianfeng Xu, Jeffrey N. Weitzel, Gerald L. Andriole, Himisha Beltran, Alberto Briganti, Lindsey Byrne, Anne Calvaresi, Thenappan Chandrasekar, David Y.T. Chen, Robert B. Den, Albert Dobi, E. David Crawford, James A. Eastham, Scott E. Eggener, Matthew L. Freedman, Marc B. Garnick, Patrick T. Gomella, Nathan Handley, Mark Hurwitz, Joseph K. Izes, R. Jeffrey Karnes, Costas D. Lallas, Lucia R. Languino, Stacy Loeb, Ana María López, Kevin R. Loughlin, Grace Lu‐Yao, S. Bruce Malkowicz, Mark Mann, Patrick Mille, Martin Miner, Todd M. Morgan, José Moreno, Lorelei A. Mucci, Ronald E. Myers, Sarah M. Nielsen, Brock O’Neil, Wayne H. Pinover, Peter A. Pinto, Wendy Poage, Ganesh V. Raj, Timothy R. Rebbeck, Charles J. Ryan, Howard M. Sandler, Matthew J. Schiewer, Emily Scott, Brittany M. Szymaniak, William Tester, Edouard J. Trabulsi, Neha Vapiwala, Evan Y. Yu, Charnita Zeigler‐Johnson, Leonard G. Gomella - Journal of Clinical Oncology 2020 被引用: 279

  18. Primary analysis from DS8201-A-U105: A phase 1b, two-part, open-label study of trastuzumab deruxtecan (T-DXd) with nivolumab (nivo) in patients (pts) with HER2-expressing urothelial carcinoma (UC).

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 85

  19. Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study

    著者: , , , , , , , , , , , , , , , , , , , , , - European Urology 2022 被引用: 79

  20. IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2021 被引用: 67

  21. Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

    著者: , , , , , , , , , , , , , , , , , , - The Lancet 2010 被引用: 1,084

  22. Disparities in Cancer Care and the Asian American Population

    著者: , , , , - The Oncologist 2021 被引用: 141

  23. A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer

    著者: , , , , , , , , , , , - PLoS ONE 2018 被引用: 137

  24. Genome-wide genotype-serum proteome mapping provides insights into the cross-ancestry differences in cardiometabolic disease susceptibility

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 被引用: 60